Evaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follow

NCT00330564 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

15

Enrollment

OTHER

Sponsor class

Stopped Slow accrual.

Conditions

Von Hippel-Lindau Syndrome
Renal Cell Carcinoma
Hemangioblastoma

Interventions

DRUG: SU011248

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]